The invention relates to an enclosure of the type that comprises a base, at least one side wall, and a top cover, which delimit a decontamination space, wherein one of said at least one side walls comprises an opening extending to the top cover for access to the decontamination space, and the top cover comprises a cable passage that opens into said opening and a member for suspending a cable through said cable passage.
Enclosures of this type are known, and are used for disinfecting the active part of a medical probe intended for use with an imaging device, for example.
Disinfection can be done by using UV radiation, by atomizing a liquid disinfectant in the form of micro-droplets, or by injecting a gas disinfectant into the decontamination space of the enclosure, for example.
In such an enclosure, the active part of the probe must be suspended in the decontamination space in order to obtain the largest possible disinfection surface. In addition, the cable that joins the active part of the probe to the device with which the probe is used should preferably not be put entirely inside the enclosure, in order to protect the part of this cable that connects to the imaging device, and to optionally allow the probe not to be disconnected from the imaging device while it is being disinfected. Finally, it is vital to ensure that the decontamination space is sealed so as to prevent any disinfectant active principle from leaking out of the enclosure.
In order to make the disinfection of a probe traceable so as to prevent any wrongful use of a probe from a hygienic standpoint, it is important to be able to accurately identify the probe that is being disinfected in the enclosure. In order to provide such identification, the use of RFID-type electronic identification labels is known.
However, in an environment where many probes are present, e.g., if the enclosure is attached to an imaging device and multiple probes are plugged into this device, an RFID reader may possibly identify a probe placed nearby rather than the probe being disinfected, which can generate serious errors in tracing the disinfection of a probe.
One of the purposes of the invention is to propose a decontamination enclosure in which the probe in the enclosure can be identified with certainty.
To this end, the invention relates to a decontamination enclosure of the aforementioned type, wherein the enclosure comprises means for reading an electronic identification label provided on a cable of the medical instrument, with said label being placed near the active part of the medical instrument to be disinfected, and said reading means being arranged so as to be near the identification label when the cable is suspended on the cable suspension member.
The enclosure according to the invention thus makes it possible to ensure that the probe inside the enclosure is in fact the one that is identified.
According to other characteristics of the decontamination enclosure of the invention:
The invention also relates to a system for suspending a medical instrument, comprising a portion of cable in a decontamination enclosure as described above, characterized in that it comprises the suspension part of the fastening assembly, attached to the portion of the medical instrument cable, with said suspension part comprising an electronic identification label.
The invention also relates to a system for suspending a medical instrument, comprising a portion of cable in a decontamination enclosure as described above, characterized in that an electronic identification label is attached inside a projection on the portion of cable, wherein said projection is inserted into the cable passage, the cable passage comprising a recess to accommodate said projection, near which the reading means are located.
Other aspects and advantages of the invention will appear in the following description, given as an example and with reference to the annexed figures.
With reference to
In the embodiment shown in the figures, the decontamination enclosure 3 is attached to the imaging device 1. According to other embodiments, the enclosure 3 is independent of the imaging device 1 or is attached to another medical apparatus.
In the embodiment shown in the figures, three probes 2 are connected to the imaging device 1. According to other embodiments, a different number of probes can be provided. The imaging device 1 is known in itself and will not be described in more detail here. A probe 2 comprises an active part 4 that must be disinfected before each use and a cable 5 for connecting to the medical apparatus 1, the connecting part of which must not be exposed to the active principle used in the disinfection process. The probe 2 is known in itself and will not be described in more detail here.
The enclosure 3 comprises a base 6 forming the bottom of the enclosure, at least one side wall 7 forming the body of the enclosure, and a top cover 8. The side wall 7 extends between the base 6 and the top cover so as to delimit a decontamination space 9 in which the active part 4 of the probe 2 is placed in order to be disinfected.
According to the embodiment shown in the figures, the enclosure 3 is substantially parallelepipedic and comprises four side walls 7. According to other embodiments, the enclosure 3 can be substantially cylindrical with circular section or otherwise.
The enclosure 3 comprises means (not shown) for diffusing a disinfectant active principle in the decontamination space 9. These means are, for example, a source of UV emission, a micro-droplet spray nozzle for a liquid disinfectant, or an injection nozzle for a gas disinfectant. The diffusion means are arranged so that the active part 4 of the probe 2 is uniformly exposed to the disinfectant active principle.
In the embodiment shown in the figures, the wall 7 opposite the imaging device comprises an opening 10 that can be closed with a door 11. The door is shown in closed position in
The cover 8 comprises a cable passage 12 that opens into the opening 10 so that the probe 2 cable 5 can pass through when the active part 4 is inserted into the decontamination space 9. The cable passage 12 comprises a slot provided in the cover 8, extending to a central part of the cover 8, as shown in
According to an embodiment shown in the figures, the cover 8 additionally comprises a flap seal 13 that is movable between a closed position (
According to another embodiment not shown, the flap 13 is integral with the top part of the door 11 and is arranged so as to close the cable passage 12 hermetically when the door is closed. Such an embodiment is particularly simple to implement and does not require any means for transmitting movement between the door 11 and the flap 13, unlike the case in which the flap 13 is borne by the cover 8.
The cover 8 additionally comprises a member 14 for suspending the cable through the cable passage 12. The cable suspension member 14 makes it possible to keep the probe 2 cable 5 in place so that the active part 4 is suspended in a substantially central part of the decontamination space 9, as shown in
According to the embodiment shown in the figures, the suspension member 14 comprises a part 15 for receiving a suspension part 16 provided on the probe 2 cable 5. The receiving part 15 and the suspension part 16 form a fastening assembly comprised of a male part and a female part. According to the embodiment shown in the figures, the male part is the receiving part 15 and the female part is the suspension part 16.
According to an embodiment, the fastening assembly is arranged so that the cable 5 is oriented in a particular way when the suspension part 16 is attached onto the receiving part 15. For example, the cable is oriented by screwing the suspension part 16 onto the receiving part 15 until an abutting position is reached.
As shown in
According to other embodiments not shown, the suspension member 14 comprises a clamp, a hook, or an open tube that can be hermetically fitted over a portion of cable 5 whose diameter is within a range of predetermined diameters. According to various embodiments, means are provided for orienting the cable 5, e.g., by indexing or other means, so that the cable has a predetermined orientation when the active part 4 is suspended in the decontamination space 9.
The probe 2 comprises identification means in the form of an electronic identification label 17, e.g., an RFID chip. This chip contains information on the identity of the probe. The label 17 is attached to the cable 5, for example, near the suspension member 14 when the active part 4 of the probe 2 is suspended in the decontamination space 9. According to an embodiment, the label 17 is attached or embedded in the suspension part 16, as shown in
The enclosure comprises means 18 for reading the electronic identification label, e.g., an RFID-type reader. The reading means 18 are arranged so as to be near the identification label 17 when the cable 5 is suspended on the cable suspension member 15, so that the reading means 18 can read the identification information in the identification label 17. Placing the reading means near the identification label can be made simpler by the cable 5 orientation means. According to an embodiment, the reading means 18 are provided with the suspension member 15 or integrated therewith, as shown in
According to another embodiment not shown, the electronic identification label 17 is attached on the inside of a projection of the cable 5, which is inserted into the cable passage 12. The cable passage 12 comprises a recess to accommodate the projection, near which the reading means 18 are placed. A recess is provided, for example, at the end of the slot provided in the cover 8, into which the projection fits when the cable 5 is suspended in the enclosure. The reading means 18 near the recess make it possible to read the content of the identification label 17 attached inside the projection. The projection is arranged to fit into the recess in such a way that the enclosure 9 is hermetically closed when the active part 4 of the probe is inserted into the enclosure.
The identification label 17 of the probe 2 can operate in tandem with means (not shown) for measuring disinfection characteristics in order to make the disinfection of the probe traceable. For example, means can be provided for measuring the intensity of the UV radiation and the length of time the active part 4 is exposed to this radiation, if UV disinfection is used. This information can be recorded in the identification label of the probe or in the imaging device 1 with the identity of the probe 2. In this way, the probe identification information is paired with the disinfection information for this probe so as to make the disinfection process traceable.
According to an embodiment, the imaging device 1 is set up so that it will not operate with a probe that has not been disinfected or has been inadequately disinfected.
Number | Date | Country | Kind |
---|---|---|---|
07 54548 | Apr 2007 | FR | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/FR2008/000541 | 4/16/2008 | WO | 00 | 9/30/2009 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2008/142300 | 11/27/2008 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
4772795 | Sakurai et al. | Sep 1988 | A |
5185532 | Zabsky et al. | Feb 1993 | A |
5310524 | Campbell et al. | May 1994 | A |
5610811 | Honda | Mar 1997 | A |
5641464 | Briggs, III et al. | Jun 1997 | A |
5690113 | Sliwa, Jr. et al. | Nov 1997 | A |
5761069 | Weber et al. | Jun 1998 | A |
6039928 | Roberts | Mar 2000 | A |
6171559 | Sanders et al. | Jan 2001 | B1 |
6231819 | Morello | May 2001 | B1 |
6260560 | Walta | Jul 2001 | B1 |
6475433 | McGeorge et al. | Nov 2002 | B2 |
6485979 | Kippenhan et al. | Nov 2002 | B1 |
6641781 | Walta | Nov 2003 | B2 |
7965185 | Cambre et al. | Jun 2011 | B2 |
20010024623 | Grimm et al. | Sep 2001 | A1 |
20020162972 | Pleet | Nov 2002 | A1 |
20030016122 | Petrick | Jan 2003 | A1 |
20030039579 | Lambert et al. | Feb 2003 | A1 |
20030187586 | Katzenmaier et al. | Oct 2003 | A1 |
20040009091 | Deal et al. | Jan 2004 | A1 |
20040140347 | Mihaylov et al. | Jul 2004 | A1 |
20040209223 | Beier et al. | Oct 2004 | A1 |
20050196314 | Petersen et al. | Sep 2005 | A1 |
20080213139 | Deshays | Sep 2008 | A1 |
20080219899 | Deshays | Sep 2008 | A1 |
20090169436 | Deshays | Jul 2009 | A1 |
20100140134 | Deshays | Jun 2010 | A1 |
Number | Date | Country |
---|---|---|
3209701 | Sep 1983 | DE |
3917876 | Dec 1990 | DE |
19703823 | May 1998 | DE |
19917206 | Oct 2000 | DE |
10225232 | Dec 2002 | DE |
10225857 | Jan 2004 | DE |
0 471 530 | Feb 1992 | EP |
0 630 820 | Dec 1994 | EP |
0 709 056 | May 1996 | EP |
0 709 056 | May 1996 | EP |
0839537 | May 1998 | EP |
1 402 904 | Mar 2004 | EP |
1 532 989 | May 2005 | EP |
2753905 | Apr 1998 | FR |
2890566 | Mar 2007 | FR |
2890865 | Mar 2007 | FR |
WO-8400009 | Jan 1984 | WO |
WO-9908137 | Feb 1999 | WO |
WO-2004111917 | Dec 2004 | WO |
20051048041 | May 2005 | WO |
Entry |
---|
International Search Report for PCT/FR2008/000541, mailing date of Jan. 22, 2009. |
International Search Report mailed on Jan. 22, 2009, for PCT Application No. PCT/FR2008/000540, 3 pages. |
International Search Report mailed on Sep. 11, 2007, for PCT Application No. PCT/FR2007/000594, 3 pages. |
International Search Report mailed on Jul. 6, 2006, for PCT Application No. PCT/FR2005/003032, 3 pages. |
International Search Report mailed on Mar. 21, 2006 for PCT Application No. PCT/FR2005/003031, 3 pages. |
Number | Date | Country | |
---|---|---|---|
20100140342 A1 | Jun 2010 | US |